Description: This report is the fifth in a series of studies conducted jointly by LIMRA and the SOA Long-Term Care Experience Committee. The report presents results for industry long-term care insurance (LTCI) persistency. Persistency is examined based on eighteen participating companies reporting lapse, mortality, and total termination activity for calendar years 2000 through 2016. The report and a supplemental Tableau database with several dashboard views can be accessed in the Materials section.

Description: Discussant comments for the 2009 Housing Wealth monograph paper, “Home Equity and At-Need Annuities—A Dynamic Long-Term Care Funding Duo”. The author finds that the ideas discussed in this paper should stimulate more thinking about financial products and public sector programs and how they can better serve older homeowners.

Description: Support systems and new solutions to enable caregivers to deliver better care and reduce personal stress.

Description: Impaired annuities - a niche product marketed to people at the “at-need” edge of long-term care and has the potential to instruct in bridging the gap for the products now being marketed to people “pre-need.” From Long-Term Care, Dec 2003, Issue No. 10

Description: This is an article about group long-term care insurance.

Description: To penetrate the market of those who today are concerned about future long-term care needs, LTCI providers will need to combine strategies for financial sustainability with the consumer- driven product design focus of the early to mid-1990s.

Description: Companies with the intention of being the top, trusted source(s) in an information overloaded world.

Description: This report describes two methods, an observation-based analysis and an actual to model analysis, to analyze long-term care insurance experience to determine if calendar year trends exist.

Description: "How long is long in longevity? – Jesús-Adrian Álvarez, Ph.D. - Danish Labour Market Supplementary Pension Fund (ATP), The Rate of Aging in humans is constant. New evidence – Marcus Ebeling, PhD., Research Group Mathematical and Actuarial Demography, Max Planck Institute for Demographic Research, Rostock, Germany, Department of Sociology and Demography, University of Rostock, Rostock, Germany; Roland Rau, Ph.D., Professor, Research Group Mathematical and Actuarial Demography, Max Planck Institute for Demographic Research, Rostock, Germany, C6 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Håkan Malmström, Ph.D., C6 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Anders Ahlbom, Ph.D., Professor Emeritus, Karen Modig, Ph.D., Associate Professor, C6 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden Human Lifetimes: Finite But Not Necessarily Bounded – Fei Huang, PhD., School of Risk & Actuarial Studies, UNSW Sydney; Ross Maller, Ph.D., Emeritus Professor, Xu Ning, Ph.D., Research School of Finance, Actuarial Studies & Statistics, Australian National University, Brandon Milholland, Ph.D., IQVIA Plymouth Meeting, PA."

Description: Find out more about the inforce product rate management process for health and LTC products. Requirements can vary by state, by issue era, and by product type and in some cases require filings to certify compliance on a regular basis. Discover recent trends in inforce rate management in the industry, including any changes seen coinciding with COVID-19 and its impacts to the regulators. By attending this session, you will be able to: • Describe or perform an inforce rate management for health products. • Understand the applicable state regulations. • Be informed of current industry trends for this work.